UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

~~WASHINGTON,~~ ~~D.C.~~FORM ~~20549~~8-KCURRENT REPORT

~~FORM 8-K~~ Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~CURRENT~~ Date ~~REPORT~~of Report (Date of earliest event reported): September 28, 2006

~~Pursuant~~MediCor toLtd. ~~Section 13~~(Exact orname ~~15(d)~~ of ~~the~~Registrant as Specified in its Charter)

Securities Exchange Act of 1934

Delaware		0-50442		14-1871462
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

~~Date~~4560 ofSouth ~~Report~~ Decatur Boulevard, Suite 300, Las Vegas, NV 89103 (~~Date~~Address of ~~earliest~~Principal ~~event~~Executive ~~reported~~Offices): ~~July 6~~(702) 932-4560 (Registrant’s Telephone Number, ~~2006~~Including Area Code) Not Applicable (Former Name or Former Address, if Changed Since Last Report)

~~MediCor~~ Check the appropriate box below if ~~Ltd.~~the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (~~Exact~~17 ~~name~~CFR ~~of Registrant~~230.425) aso ~~Specified~~Soliciting inmaterial ~~its~~pursuant ~~Charter~~to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Delaware		000-50442		14-1871462
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Item 2.02 Results of Operations and Financial Condition

~~4560~~ ~~South~~ MediCor, ~~Decatur~~Ltd. ~~Boulevard,~~(the ~~Suite 300~~“Company”) issued a press release on September 28, ~~Las~~2006. The ~~Vegas~~press release announced the Company’s financial results for the fiscal year ended June 30, NV2006. A ~~89103 (Address~~copy of ~~Principal~~the ~~Executive~~press ~~Offices)~~release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

~~(702) 932-4560~~ ~~(Registrant’s~~Item ~~Telephone~~9.01 Financial ~~Number,~~Statements ~~Including~~and ~~Area Code)~~Exhibits

~~Not~~ ~~Applicable~~ (~~Former Name or Former Address, if Changed Since Last Report~~d) Exhibits

Item 1.01 Entry into a Material Definitive Agreement.

Exhibit No.		Description

99.1		Copy of press release issued by the Company on September 28, 2006

As reported in Item 5.02 of this Current Report on Form 8-K, on July 6, 2006, the Board of Directors of MediCor Ltd. (the “Company”) appointed three new independent directors. The compensation of the directors will be the same as for all independent directors, which compensation is as follows:SIGNATURES

~~(i) an~~ ~~annual~~ Pursuant ~~fee~~to the requirements of ~~$12~~the Securities Exchange Act of 1934,~~000;~~ the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

~~(ii) a fee~~MEDICOR, ofLTD. ~~$500~~By: ~~for~~/s/ ~~each~~Theodore ~~meeting~~R ofMaloney ~~the~~Name: ~~Board~~Theodore ofR. ~~Directors~~Maloney ~~attended~~Title: orChief ~~committee meeting~~Executive ~~separate from a Board meeting that they chair;~~Officer

~~(iii) reimbursement~~ Dated: ofSeptember ~~expenses;~~28, 2006

(iv) upon their initial selection, a grant of 10,000 common stock equivalents; and

(v) thereafter, a grant of 20,000 common stock equivalents at each annual stockholders meeting of the Company, so long as they remain directors.

Directors who are employees of the Company are not entitled to any compensation for their service as a director.

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On July 6, 2006, the Board of Directors of the Company increased the fixed number of members of the Board of Directors from six to nine, and appointed three new directors, Robert L. Forbuss, Eugene I. Davis and Ikram U. Khan, M.D., to fill the newly created vacancies. Mr. Forbuss was appointed as a Class III director to serve through the 2006 annual meeting of stockholders, and was appointed to serve as a member of the Audit Committee. Mr. Davis was appointed as a Class I director to serve through the 2007 annual meeting of stockholders, and was appointed to serve as a member of the Compensation Committee. Dr. Khan was appointed as a Class II director to serve through the 2008 annual meeting of stockholders, and was appointed to serve as a member of the Corporate Governance and Nominating Committee.

The Company issued a press release on July 7, 2006 announcing the board appointments. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No.		Description
99.1		Copy of press release issued by the Company on July 7, 2006 announcing the appointment of three new directors to fill vacancies

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

MEDICOR, LTD. By: /s/ Theodore R Maloney Name: Theodore R. Maloney Title: Chief Executive Officer

Date: July 12, 2006

Filing Compare · MEDICOR LTD